U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07807046) titled 'TwichView-guided Atricurium Dose Adjustment Trial' on Aug. 21.
Brief Summary: The goal of this clinical trial is to learn if using a monitor that measures muscle response can lower the amount of muscle relaxant medicine needed in adults who are treated in an intensive care unit (ICU) and need a continuous drip of a muscle relaxant called atracurium for more than 48 hours. The main questions it aims to answer are:
Does using the monitor lower the infusion rate and total amount of atracurium given over 72 hours? Does using the monitor lower the complications related to atracurium use?
Researchers will compare a group whose dose is g...